PlainRecalls
FDA Drug Moderate Class II Terminated

Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-453-01.

Reported: September 25, 2019 Initiated: September 6, 2019 #D-1862-2019

Product Description

Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-453-01.

Reason for Recall

Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.

Details

Recalling Firm
Torrent Pharma Inc.
Units Affected
2472 bottles
Distribution
Nationwide in the USA and Puerto Rico
Location
Basking Ridge, NJ

Frequently Asked Questions

What product was recalled?
Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-453-01.. Recalled by Torrent Pharma Inc.. Units affected: 2472 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 25, 2019. Severity: Moderate. Recall number: D-1862-2019.